A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"

Clinical trial NCT06184269 · COMPLETED

Trial details

NCT number: NCT06184269
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Essential Hypertension Primary Hypercholesterolemia

Start date: 2023-12-23
Primary completion: 2024-02-18
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.